Floatz logo

8 assets in Nodular Sclerosis Classical Hodgkin Lymphoma

Therapeutic assets addressing Nodular Sclerosis Classical Hodgkin Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Adriamycin
Nodular Sclerosis Classical Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (69)
Nivestim
Nodular Sclerosis Classical Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (69)
Bleomycin
Nodular Sclerosis Classical Hodgkin Lymphoma
City of Hope Medical CenterP3BB (68)
Brentuximab Vedotin
Nodular Sclerosis Classical Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (66)
Dacarbazine
Nodular Sclerosis Classical Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (66)
Vinblastine
Nodular Sclerosis Classical Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (66)
Nivolumab
Nodular Sclerosis Classical Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (64)
Pegfilgrastim
Nodular Sclerosis Classical Hodgkin Lymphoma
National Cancer Institute (NCI)P3B (60)